(Q38424589)

3 September 2017

title

Comparative effectiveness of anti-tumor necrosis factor drugs on health-related quality of life among patients with inflammatory arthritis (English)

1 reference

3 September 2017

4

Rachelle Buchbinder

1 reference

3 September 2017

Jian Sheng Chen

1

1 reference

3 September 2017

Joanna Makovey

series ordinal

2

1 reference

3 September 2017

Marissa Lassere

series ordinal

3

1 reference

3 September 2017

Lyn M March

series ordinal

5

1 reference

3 September 2017

publication date

1 March 2014

1 reference

Arthritis Care and Research

3 September 2017

published in

1 reference

3 September 2017

volume

66

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

464-472

1 reference

3 September 2017

1 reference

Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity

21 January 2018

1 reference

Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis

21 January 2018

1 reference

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis

21 January 2018

1 reference

A randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 years

21 January 2018

1 reference

Baseline comorbidities in a population-based cohort of rheumatoid arthritis patients receiving biological therapy: data from the Australian rheumatology association database

21 January 2018

1 reference

Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database.

21 January 2018

1 reference

The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms

21 January 2018

1 reference

Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

21 January 2018

1 reference

The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life

21 January 2018

1 reference

Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure.

21 January 2018

1 reference

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis

21 January 2018

1 reference

The minimally important difference for patient-reported outcomes in spondyloarthropathies including pain, fatigue, sleep, and Health Assessment Questionnaire

21 January 2018

1 reference

The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data

21 January 2018

1 reference

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide D

21 January 2018

1 reference

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview

21 January 2018

1 reference

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation

21 January 2018

1 reference

The effectiveness of anti-TNF-alpha therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis

21 January 2018

1 reference

Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?

21 January 2018

1 reference

Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: Results from the British Society for Rheumatolo

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ACR.22151

1 reference

3 September 2017

1 reference